Pictet Asset Management (Switzerland)’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $19.1M | Buy |
1,841,997
+387,730
| +27% | +$4.01M | 0.02% | 480 |
|
|
2023
Q1 | $15.8M | Buy |
1,454,267
+961,879
| +195% | +$10.4M | 0.02% | 515 |
|
|
2022
Q4 | $5.53M | Buy |
492,388
+122,009
| +33% | +$1.37M | 0.01% | 717 |
|
|
2022
Q3 | $3.76M | Buy |
370,379
+108,952
| +42% | +$1.1M | 0.01% | 794 |
|
|
2022
Q2 | $2.37M | Buy |
261,427
+74,643
| +40% | +$676K | ﹤0.01% | 912 |
|
|
2022
Q1 | $1.79M | Sell |
186,784
-16,732
| -8% | -$160K | ﹤0.01% | 974 |
|
|
2021
Q4 | $2.25M | Hold |
203,516
| – | – | ﹤0.01% | 979 |
|
|
2021
Q3 | $1.51M | Buy |
+203,516
| New | +$1.51M | ﹤0.01% | 1021 |
|